Login / Register
Menu
About us
Products
Primary antibodies
Gallery
Distributors
Validation
Tissue Microarrays
Publications
Large Scale Studies
Further Publications
Events
Quiz
Contact
About us
Products
Primary antibodies
Gallery
Distributors
Validation
Tissue Microarrays
Publications
Large Scale Studies
Further Publications
Events
Quiz
Contact
Search
×
Cancer Tissue Gallery MUC2
Path
Created with Sketch.
Go to MUC2 Normal Tissue Gallery
Go back to Product Page
Adrenal gland – MUC2 negative adrenocortical adenoma
Adrenal gland – MUC2 negative adrenocortical adenoma
Adrenal gland – MUC2 negative pheochromocytoma
Adrenal gland – MUC2 negative pheochromocytoma
Anal canal – MUC2 negative squamous cell carcinoma
Anal canal – MUC2 negative squamous cell carcinoma
Breast – Invasive breast cancer of no special type (NST) with strong MUC2 staining of virtually all tumor cells
Breast – Invasive breast cancer of no special type (NST) with strong MUC2 staining of virtually all tumor cells
Breast – MUC2 negative invasive breast cancer of no special type (NST)
Breast – MUC2 negative invasive breast cancer of no special type (NST)
Breast – MUC2 negative invasive lobular breast cancer
Breast – MUC2 negative invasive lobular breast cancer
Colon – Colorectal adenocarcinoma with intense MUC2 staining of tumor cells
Colon – Colorectal adenocarcinoma with intense MUC2 staining of tumor cells
Colon – Colorectal adenocarcinoma with strong MUC2 staining of most tumor cells
Colon – Colorectal adenocarcinoma with strong MUC2 staining of most tumor cells
Colon – Colorectal adenocarcinoma with strong MUC2 staining of tumoral goblet cells and of mucus
Colon – Colorectal adenocarcinoma with strong MUC2 staining of tumoral goblet cells and of mucus
Colon – MUC2 negative colorectal adenocarcinoma
Colon – MUC2 negative colorectal adenocarcinoma
Esophagus – Adenocarcinoma with strong MUC2 immunostaining of all tumor cells
Esophagus – Adenocarcinoma with strong MUC2 immunostaining of all tumor cells
Kidney – MUC2 negative clear cell carcinoma
Kidney – MUC2 negative clear cell carcinoma
Kidney – MUC2 negative papillary renal cell carcinoma
Kidney – MUC2 negative papillary renal cell carcinoma
Liver – MUC2 negative hepatocellular carcinoma
Liver – MUC2 negative hepatocellular carcinoma
Lung – Adenocarcinoma with weak to moderate MUC2 staining of tumor cells. Strong MUC2 positivity of intratumoral mucus
Lung – Adenocarcinoma with weak to moderate MUC2 staining of tumor cells. Strong MUC2 positivity of intratumoral mucus
Lung – MUC2 negative adenocarcinoma
Lung – MUC2 negative adenocarcinoma
Lymph node – MUC2 negative Hodgkin’s lymphoma
Lymph node – MUC2 negative Hodgkin’s lymphoma
Pancreas – Adenocarcinoma of the papilla Vaterii with strong MUC2 staining of tumoral goblet cells
Pancreas – Adenocarcinoma of the papilla Vaterii with strong MUC2 staining of tumoral goblet cells
Pancreas – Ductal adenocarcinoma with strong MUC2 staining of some tumoral goblet cells
Pancreas – Ductal adenocarcinoma with strong MUC2 staining of some tumoral goblet cells
Pancreas – MUC2 negative neuroendocrine tumor
Pancreas – MUC2 negative neuroendocrine tumor
Prostate – Adenocarcinoma (Gleason 5+5=10) with strong MUC2 positivity of a subset of tumor cells
Prostate – Adenocarcinoma (Gleason 5+5=10) with strong MUC2 positivity of a subset of tumor cells
Prostate – Adenocarcinoma with strong MUC2 staining of a fraction of tumor cells
Prostate – Adenocarcinoma with strong MUC2 staining of a fraction of tumor cells
Prostate – MUC2 negative adenocarcinoma (Gleason 3+3=6)
Prostate – MUC2 negative adenocarcinoma (Gleason 3+3=6)
Salivary gland –MUC2 negative Warthin tumor
Salivary gland –MUC2 negative Warthin tumor
Stomach – Gastric adenocarcinoma (diffuse type) with intense MUC2 positivity of all tumor cells
Stomach – Gastric adenocarcinoma (diffuse type) with intense MUC2 positivity of all tumor cells
Stomach – Gastric adenocarcinoma (diffuse type) with strong MUC2 positivity of a fraction of tumor cells
Stomach – Gastric adenocarcinoma (diffuse type) with strong MUC2 positivity of a fraction of tumor cells
Stomach – MUC2 negative adenocarcinoma
Stomach – MUC2 negative adenocarcinoma
Testis – MUC2 negative seminoma
Testis – MUC2 negative seminoma
Thyroid – MUC2 negative papillary carcinoma
Thyroid – MUC2 negative papillary carcinoma
Urinary bladder – Muscle-invasive urothelial carcinoma with strong MUC2 immunostaining of all tumor cells
Urinary bladder – Muscle-invasive urothelial carcinoma with strong MUC2 immunostaining of all tumor cells
Uterus – Endometroid endometrium carcinoma with weak to moderate MUC2 staining of tumor cells. Strong MUC2 positivity of intratumoral mucus
Uterus – Endometroid endometrium carcinoma with weak to moderate MUC2 staining of tumor cells. Strong MUC2 positivity of intratumoral mucus
Uterus, cervix – MUC2 negative adenocarcinoma
Uterus, cervix – MUC2 negative adenocarcinoma